Paper41962001
TFPIα inhibition by andexanet alfa is partially restored by protein S and factor V-short.
Crossette-Thambiah C and 3 others. Blood Adv, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. TFPIα inhibition by andexanet alfa is partially restored by protein S and factor V-short. Papers, record 41962001. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41962001
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- TFPIα inhibition by andexanet alfa is partially restored by protein S and factor V-short.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lipoproteins | Major topic |
| Factor Xa | Major topic |
| Protein S | Major topic |
| Factor V | Major topic |
| Humans | |
| Recombinant Proteins | |
| Factor Xa Inhibitors | |
| Thrombin | |
| Rivaroxaban |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37,841,511 | Toward non-factor therapy in hemophilia: an antithrombin insensitive Gla-domainless factor Xa as tissue factor pathway inhibitor bait. | Res Pract Thromb Haemost | 2023 | https://conductscience.org/library/papers/37841511 | PubMed |
| 2 | 21,508,412 | Activated protein C cofactor function of protein S: a novel role for a γ-carboxyglutamic acid residue. | Blood | 2011 | https://conductscience.org/library/papers/21508412 | PubMed |
| 3 | 37,467,256 | A sensitive tissue factor activity assay determined by an optimized thrombin generation method. | PLoS One | 2023 | https://conductscience.org/library/papers/37467256 | PubMed |
| 4 | 38,306,422 | TFPIα anticoagulant function is highly dependent on protein S in vivo. | Sci Adv | 2024 | https://conductscience.org/library/papers/38306422 | PubMed |
| 5 | 8,725,726 | Factor Xa enhances the binding of tissue factor pathway inhibitor to acidic phospholipids. | Thromb Haemost | 1996 | https://conductscience.org/library/papers/8725726 | PubMed |
| 6 | 20,308,596 | Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain. | Blood | 2010 | https://conductscience.org/library/papers/20308596 | PubMed |
| 7 | 29,296,829 | Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa. | Blood Adv | 2017 | https://conductscience.org/library/papers/29296829 | PubMed |
| 8 | 30,730,782 | Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors. | N Engl J Med | 2019 | https://conductscience.org/library/papers/30730782 | PubMed |
| 9 | 35,247,027 | A hydrophobic patch (PLVIVG; 1481-1486) in the B-domain of factor V-short is crucial for its synergistic TFPIα-cofactor activity with protein S and for the formation of the FXa-inhibitory complex comprising FV-short, TFPIα, and protein S. | J Thromb Haemost | 2022 | https://conductscience.org/library/papers/35247027 | PubMed |
| 10 | 25,163,770 | Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs. | J Thromb Haemost | 2014 | https://conductscience.org/library/papers/25163770 | PubMed |
| 11 | 20,002,538 | Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma. | J Thromb Haemost | 2010 | https://conductscience.org/library/papers/20002538 | PubMed |
| 12 | 31,668,248 | FDA Approval of Andexanet Alfa Based on a Single-Arm Trial: If There Is a Villain, Who Is It? | Ann Emerg Med | 2019 | https://conductscience.org/library/papers/31668248 | PubMed |
| 13 | 32,092,140 | A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers. | Blood Adv | 2020 | https://conductscience.org/library/papers/32092140 | PubMed |
| 14 | 18,695,002 | Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. | Blood | 2008 | https://conductscience.org/library/papers/18695002 | PubMed |
| 15 | 34,731,882 | Laminin G1 residues of protein S mediate its TFPI cofactor function and are competitively regulated by C4BP. | Blood Adv | 2022 | https://conductscience.org/library/papers/34731882 | PubMed |
| 16 | 24,233,490 | Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor. | Arterioscler Thromb Vasc Biol | 2014 | https://conductscience.org/library/papers/24233490 | PubMed |
| 17 | 23,455,714 | A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. | Nat Med | 2013 | https://conductscience.org/library/papers/23455714 | PubMed |
| 18 | 3,422,166 | The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. | Blood | 1988 | https://conductscience.org/library/papers/3422166 | PubMed |
| 19 | 12,560,220 | Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis. | Blood | 2003 | https://conductscience.org/library/papers/12560220 | PubMed |
| 20 | 15,467,899 | Total tissue factor pathway inhibitor is an independent risk factor for symptomatic paediatric venous thromboembolism and stroke. | Thromb Haemost | 2004 | https://conductscience.org/library/papers/15467899 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| F10 | 2,159 | PubTator's text mining | https://conductscience.org/library/genes/2159 | NCBI Gene |
| F2 | 2,147 | PubTator's text mining | https://conductscience.org/library/genes/2147 | NCBI Gene |
| F5 | 2,153 | PubTator's text mining | https://conductscience.org/library/genes/2153 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41962001
GET https://conductscience.org/api/papers/v1/41962001/references?page=2